Age, Symptomatic Metastatic Disease, and Malignant Pleural Effusion as Predictors of Poor Prognosis in Patients with Differentiated Thyroid Carcinoma Treated with Lenvatinib.

• Material Type: 博士論文
• Title: Age, Symptomatic Metastatic Disease, and Malignant Pleural Effusion as Predictors of Poor Prognosis in Patients with Differentiated Thyroid Carcinoma Treated with Lenvatinib.
• Volume: 63
• Author/Editor: 中嶋, 遥美
• Author Heading: 中嶋, 遥美
• Publication, Distribution, etc.: Nagasaki University School of Medicine
• Publication Date: 2021-03-22; 63
• Publication Date (W3CDTF): 2021-03-22
• Alternative Title: 年齢、症候性転移病変、癌性胸水は、レンバチニブで治療された分化型甲状腺癌患者の予後不良因子である。
• Periodical title: Acta Medica Nagasakiensia
• Pages: 71-77
• ISSN (Periodical Title): 00016055
• Degree Grantor: Nagasaki University (長崎大学)
• Date Granted: 2021-03-22
• Date Granted (W3CDTF): 2021-03-22
• Dissertation Number: 甲共医歯薬第9号
• Degree Type: 博士(医学)
• Conferring No. (Dissertation): 甲共医歯薬第9号
• Text Language Code: eng
• Subject Heading: differentiated thyroid carcinoma; lenvatinib; prognosis
• Target Audience: 一般
• Note (General): 長崎大学学位論文 学位記番号:共博(医歯薬)甲第9号 学位授与年月日:令和3年3月22日; Author: Yomi Nakashima, Takao Ando, Aya Nozaki, Ayako Ito, Ichiro Horie,Misa Imaizumi, Toshiro Usa and Atsushi Kawakami; Acta Medica Nagasakiensia, 63, pp.71−77; 2020; Nagasaki University (長崎大学), 博士(医学) (2021-03-22); 機関リポジトリ記載の権利情報: (C) 2020 Nagasaki University School of Medicine
• Persistent ID (NDL): info:ndljp/pid/11671557; https://dl.ndl.go.jp/pid/11671557
• Collection: 障害者向け資料
• Collection (Materials For Handicapped People:1): テキストデータ
• Collection (particular): 国立国会図書館デジタルコレクション > デジタル化資料 > 博士論文; https://dl.ndl.go.jp/collections/A00014
• Acquisition Basis: 博士論文（自動収集）
• Date Accepted (W3CDTF): 2021-05-16T23:51:55+09:00
• Format (IMT): PDF
• Access Restrictions: 国立国会図書館内限定公開
• Service for the Digitized Contents Transmission Service: 図書館・個人送信対象外
• Availability of remote photoduplication service: 可
• Related Material (URI): http://hdl.handle.net/10069/40722
• Periodical Title (URI): http://hdl.handle.net/10069/00040733
• Data Provider (Database): 国立国会図書館 : 国立国会図書館デジタルコレクション; https://dl.ndl.go.jp

• Summary, etc.: Background: Lenvatinib is one of the few therapeutic options available for radioiodine-refractory thyroid cancer. However, the factors that determine ...